Geode Capital Management’s Gain Therapeutics GANX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $523K | Buy |
|
|||||
|
2025
Q1 | $539K | Buy |
|
|||||
|
2024
Q4 | $578K | Sell |
|
|||||
|
2024
Q3 | $484K | Buy |
|
|||||
|
2024
Q2 | $235K | Buy |
|
|||||
|
2024
Q1 | $668K | Buy |
|
|||||
|
2023
Q4 | $495K | Hold |
|
|||||
|
2023
Q3 | $489K | Buy |
|
|||||
|
2023
Q2 | $621K | Buy |
|
|||||
|
2023
Q1 | $454K | Buy |
|
|||||
|
2022
Q4 | $282K | Buy |
|
|||||
|
2022
Q3 | $286K | Buy |
|
|||||
|
2022
Q2 | $92K | Buy |
|
|||||
|
2022
Q1 | $104K | Buy |
|
|||||
|
2021
Q4 | $107K | Buy |
|